Owkin 与赛诺菲合作开发药物研发 AI 智能体
Public reviewed event · Fri Jun 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
Event summary
据 Owkin 官方公告，与赛诺菲开展多年合作，共同开发生物医药 AI 智能体，安排包含五年许可。该信息属于商业研发安排。
Public evidence and original sources
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license
Owkin official newsroom